adMare
News

Pathway to Cures Invests in SeraGene Therapeutics

adMare BioInnovations Celebrates Successes of adMare Tx Accelerator Companies, Concludes Ontario Partnership with MaRS

adMare Academy Opens Applications for Cohort VII of its Executive Institute 

adMare BioInnovations Welcomes Five New Start-Ups in the National Tx Accelerator 

adMare BioInnovations and MaRS Discovery District Welcome Inaugural Ontario Start-Ups to Therapeutics Accelerator Program

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

MaRS partners with adMare BioInnovations to develop Therapeutics Accelerator

adMare BioInnovations Launches the adMare Tx Accelerator to Support Growth of Promising Early-stage Therapeutics Ventures across Canada

adMare BioInnovations Collaborates with Accelerator Company, Molecular Forecaster Inc. on Computational Approaches to Drug Discovery

MONTREAL, QUEBEC, April 5, 2022 – Molecular Forecaster Inc. (MFI) is excited to announce a partnership with adMare BioInnovations (adMare) to deliver computer-aided drug design (CADD) resources to selected R&D…